Emicizumab dose capping in obese patients with Haemophilia A: Early outcomes at a single centre.

Krumb, Evelien; Lambert, Catherine; Hermans, Cedric

Krumb, Evelien; Lambert, Catherine; Hermans, Cedric.

Affiliation

Krumb E; Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Lambert C; Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Hermans C; Hemostasis and Thrombosis Unit, Division of Hematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Haemophilia ; 28(6): e245-e247, 2022 11.

Article in En | MEDLINE | ID: mdl-35971891

Subject(s)

Antibodies, Bispecific; Hemophilia A; Humans; Hemophilia A/complications; Hemophilia A/drug therapy; Antibodies, Bispecific/therapeutic use; Antibodies, Monoclonal, Humanized/adverse effects; Obesity/complications; Obesity/drug therapy; Factor VIII

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Bispecific / Hemophilia A Limits: Humans Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Belgium Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google